MoneyWorks4Me

SMS Lifesciences - Quaterly Results

11 Aug 2025 Evaluate
A decrease in the sales to Rs. 790.43 millions was observed for the quarter ended June 2025. The sales stood at Rs. 865.71 millions during the similar quarter previous year.The Net proft of the company remain more or less same to Rs. 51.59  millions from Rs. 64.60 millions ,decline by -20.14%.A decline of 118.46 millions was observed in the OP in the quarter ended June 2025 from 141.96 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 790.43 865.71 -8.70 790.43 865.71 -8.70 3333.71 3000.02 11.12
Other Income 10.09 4.30 134.65 10.09 4.30 134.65 39.46 38.37 2.84
PBIDT 118.46 141.96 -16.55 118.46 141.96 -16.55 481.77 382.68 25.89
Interest 17.33 21.59 -19.73 17.33 21.59 -19.73 78.81 89.02 -11.47
PBDT 101.13 120.37 -15.98 101.13 120.37 -15.98 402.96 293.66 37.22
Depreciation 26.34 25.00 5.36 26.34 25.00 5.36 102.56 102.54 0.02
PBT 74.79 95.37 -21.58 74.79 95.37 -21.58 300.40 191.12 57.18
TAX 23.20 30.77 -24.60 23.20 30.77 -24.60 86.70 60.47 43.38
Deferred Tax 0.70 0.77 -9.09 0.70 0.77 -9.09 -1.41 19.94 -107.07
PAT 51.59 64.60 -20.14 51.59 64.60 -20.14 213.70 130.65 63.57
Equity 30.23 30.23 0.00 30.23 30.23 0.00 30.23 30.23 0.00
PBIDTM(%) 14.99 16.40 -8.61 14.99 16.40 -8.61 14.45 12.76 13.29
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..